Evidence map›Paper›PMID 31375767›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Oxyntic gland neoplasm of the stomach: expanding the spectrum and proposal of terminology.

Tetsuo Ushiku, Akiko Kunita, Ryohei Kuroda, Aya Shinozaki-Ushiku, Sho Yamazawa, Yosuke Tsuji, Mitsuhiro Fujishiro, Masashi Fukayama

Abstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Gastric Adenomas and Mimickers: A Review.Diagnostics (Basel, Switzerland) · 2026
    Review
  4. Article
  5. A Case of Oxyntic Gland Neoplasm Incidentally Found During Upper Endoscopic Screening.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Contract to kill: GNAS mutation.Molecular cancer · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Gastric adenocarcinoma of the fundic gland type: A review of the literature.JGH open : an open access journal of gastroenterology and hepatology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Clinicopathological features ofBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. usikut-tky@umin.ac.jp.ORCID http://orcid.org/0000-0002-1763-8380
Akiko KunitaDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ryohei KurodaDepartment of Pathology, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
Aya Shinozaki-UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Sho YamazawaDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yosuke TsujiDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Mitsuhiro FujishiroDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masashi FukayamaDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPNational Center for Global Health and Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric neoplasms exhibiting oxyntic gland differentiation typically are composed of cells with mild cytonuclear atypia differentiating to chief cells and to a lesser extent, parietal cells. Such tumors with atypical features have been reported also and terminology for this entity remains a matter of considerable debate. We analyzed and classified 26 tumors as oxyntic gland neoplasms within mucosa (group A, eight tumors) and with submucosal invasion. The latter was divided further into those with typical histologic features (group B, 14 tumors) and atypical features, including high-grade nuclear or architectural abnormality and presence of atypical cellular differentiation (group C, four tumors). Groups A and B tumors shared similar histologic features displaying either a chief cell predominant pattern characterized by monotonous chief cell proliferation, or a well-differentiated mixed cell pattern showing admixture of chief and parietal cells resembling fundic gland. In addition, group C tumors displayed atypical cellular differentiation, including mucous neck cell and foveolar epithelium. Moderate or even marked cytological atypia was noted in group C, whereas it was usually mild in the other groups except for three group B tumors with focal moderate atypia. More than 1000 μm submucosal invasion and lymphovascular invasions were recognized only in group C. Mutation analyses identified KRAS mutation in one group C tumor as well as GNAS mutation in in one group A and group B tumors. Intramucosal tumors appear to behave biologically benign and should be classified as "oxyntic gland adenoma". Those with submucosal invasion also have low malignant potential; however, a subset will have atypical features associated with aggressive histologic features and should be designated as "adenocarcinoma of fundic gland type". Especially, we suggest "adenocarcinoma of fundic gland mucosa type" for tumors with submucosal invasion exhibiting atypical cellular differentiation, because the feature is likely to be a sign of aggressive phenotype.

Indexed as

Terminology as TopicAdultAgedAged, 80 and overBiomarkers, TumorCell DifferentiationChromograninsFemaleGenetic Predisposition to DiseaseGTP-Binding Protein alpha Subunits, GsHumansMaleMiddle AgedMutationNeoplasm GradingNeoplasm InvasivenessBiomarkers, TumorChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, GsKRAS protein, humanProto-Oncogene Proteins p21(ras)

Identifiers

PMID31375767
OpenAlexW2965984203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.